Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Allergy, Asthma and Clinical Immunology

Volumn 9, Issue 1, 2013, Pages

  Stoevesandt, Johanna ^a   Hofmann, Bernd ^a,b   Hain, Johannes ^c   Kerstan, Andreas ^a   Trautmann, Axel ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anaphylaxis; Double sensitization; Field sting; Honey bee; Hymenoptera venom; Immunotherapy; Relapse; Risk factor; Treatment failure; Vespula

Indexed keywords

ALK DEPOT SQ; ALK LYOPHILISIERT SQ; BEE VENOM; RELESS; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLERGY TEST; ANAPHYLAXIS; ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SENSITIZATION; FEMALE; HONEYBEE; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INSECT STING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROTECTION; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TREATMENT FAILURE; VESPULA;

EID: 84883829301     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-9-33     Document Type: Article

References (46)

1. Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, Tracy JM, Bernstein D, Blessing-Moore J, Cox L. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011, 127:852-854. e851-823, 10.1016/j.jaci.2011.01.025, 21458655.
2. Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, Nasser SM. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy 2011, 41:1201-1220. 10.1111/j.1365-2222.2011.03788.x, 21848758.
3. Bonifazi F, Jutel M, Bilò BM, Birnbaum J, Müller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005, 60:1459-1470. 10.1111/j.1398-9995.2005.00960.x, 16266376.
4. Müller UR, Johansen N, Petersen AB, Fromberg-Nielsen J, Haeberli G. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5. Allergy 2009, 64:543-548. 10.1111/j.1398-9995.2008.01794.x, 19120073.
5. Müller U, Schmid-Grendelmeier P, Hausmann O, Helbling A. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy 2012, 67:1069-1073. 10.1111/j.1398-9995.2012.02847.x, 22676144.
6. Hofmann SC, Pfender N, Weckesser S, Huss-Marp J, Jakob T. Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2011, 127:265-267. 10.1016/j.jaci.2010.06.042, 20719373.
7. Mittermann I, Zidarn M, Silar M, Markovic-Housley Z, Aberer W, Korosec P, Kosnik M, Valenta R. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol 2010, 125:1300-1307. e1303, 10.1016/j.jaci.2010.03.017, 20466415.
8. Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hübsch-Müller C, Enk A. In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy 2006, 61:1220-1229. 10.1111/j.1398-9995.2006.01232.x, 16942573.
9. Hemmer W, Focke M, Kolarich D, Wilson IB, Altmann F, Wohrl S, Gotz M, Jarisch R. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. J Allergy Clin Immunol 2001, 108:1045-1052. 10.1067/mai.2001.120013, 11742287.
10. Straumann F, Bucher C, Wüthrich B. Double sensitization to honeybee and wasp venom: immunotherapy with one or with both venoms? Value of FEIA inhibition for the identification of the cross-reacting ige antibodies in double-sensitized patients to honeybee and wasp venom. Int Arch Allergy Immunol 2000, 123:268-274. 10.1159/000024453, 11112864.
11. Reisman RE, Müller UR, Wypych JI, Lazell MI. Studies of coexisting honeybee and vespid-venom sensitivity. J Allergy Clin Immunol 1984, 73:246-252. 10.1016/S0091-6749(84)80015-9, 6699307.
12. Sturm GJ, Böhm E, Trummer M, Weiglhofer I, Heinemann A, Aberer W. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy 2004, 59:1110-1117. 10.1111/j.1398-9995.2004.00400.x, 15355471.
13. Eberlein B, Krischan L, Darsow U, Ollert M, Ring J. Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants. J Allergy Clin Immunol 2012, 130:155-161. 10.1016/j.jaci.2012.02.008, 22421265.
14. Mertens M, Amler S, Moerschbacher BM, Brehler R. Cross-reactive carbohydrate determinants strongly affect the results of the basophil activation test in hymenoptera-venom allergy. Clin Exp Allergy 2010, 40:1333-1345. 10.1111/j.1365-2222.2010.03535.x, 20545702.
15. Golden DB. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 2005, 115:439-447. 10.1016/j.jaci.2005.01.005, 15753884.
16. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, Moneret-Vautrin A, Niggemann B, Rance F. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007, 62:857-871. 10.1111/j.1398-9995.2007.01421.x, 17590200.
17. Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. J Allergy Clin Immunol 2012, 130:698-704. 10.1016/j.jaci.2012.03.024, 22554708.
18. Position paper Allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy 1993, 48:48-82. Position paper.
19. Bilò BM, Ruëff F, Mosbech H, Bonifazi F, Oude-Elberink JN. Diagnosis of Hymenoptera venom allergy. Allergy 2005, 60:1339-1349. 10.1111/j.1398-9995.2005.00963.x, 16197464.
20. Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012, 10:008838.
21. Golden DB. Long-term outcome after venom immunotherapy. Curr Opin Allergy Clin Immunol 2010, 10:337-341.
22. Golden DB, Kagey-Sobotka A, Lichtenstein LM. Survey of patients after discontinuing venom immunotherapy. J Allergy Clin Immunol 2000, 105:385-390. 10.1016/S0091-6749(00)90092-7, 10669863.
23. Hafner T, DuBuske L, Kosnik M. Long-term efficacy of venom immunotherapy. Ann Allergy Asthma Immunol 2008, 100:162-165. 10.1016/S1081-1206(10)60425-5, 18320918.
24. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol 1998, 101:606-612. 10.1016/S0091-6749(98)70167-8, 9600496.
25. Reisman RE, Lantner R. Further observations of stopping venom immunotherapy: comparison of patients stopped because of a fall in serum venom-specific IgE to insignificant levels with patients stopped prematurely by self-choice. J Allergy Clin Immunol 1989, 83:1049-1054. 10.1016/0091-6749(89)90446-6, 2732405.
26. Golden DB, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol 1998, 101:298-305. 10.1016/S0091-6749(98)70239-8, 9525443.
27. Golden DB, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol 1996, 97:579-587. 10.1016/S0091-6749(96)70302-0, 8621842.
28. Oude Elberink JN, de Monchy JG, Kors JW, van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 1997, 99:153-154.
29. Light WC. Insect sting fatality 9 years after venom treatment (venom allergy, fatality). J Allergy Clin Immunol 2001, 107:925.
30. Golden DB. Fatal insect allergy after discontinuation of venom immunotherapy. J Allergy Clin Immunol 2001, 107:925-926.
31. Reisman RE. Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol 1993, 92:831-836. 10.1016/0091-6749(93)90060-S, 8258617.
32. Müller U, Berchtold E, Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 1991, 87:702-709. 10.1016/0091-6749(91)90392-2, 2005323.
33. Haugaard L, Norregaard OF, Dahl R. In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 1991, 87:699-702. 10.1016/0091-6749(91)90391-Z, 2005322.
34. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991, 88:339-348. 10.1016/0091-6749(91)90095-6, 1890261.
35. van Halteren HK, van der Linden PW, Burgers JA, Bartelink AK. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge. J Allergy Clin Immunol 1997, 100:767-770. 10.1016/S0091-6749(97)70271-9, 9438484.
36. Müller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992, 89:529-535. 10.1016/0091-6749(92)90319-W, 1740583.
37. Golden DB, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Dose dependence of Hymenoptera venom immunotherapy. J Allergy Clin Immunol 1981, 67:370-374. 10.1016/0091-6749(81)90082-8, 7229226.
38. Haeberli G, Bronnimann M, Hunziker T, Müller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003, 33:1216-1220. 10.1046/j.1365-2222.2003.01755.x, 12956741.
39. Ruëff F, Przybilla B, Bilò MB, Müller U, Scheipl F, Aberer W, Birnbaum J, Bodzenta-Lukaszyk A, Bonifazi F, Bucher C, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009, 124:1047-1054. 10.1016/j.jaci.2009.08.027, 19895993.
40. Niedoszytko M, de Monchy J, van Doormaal JJ, Jassem E, Oude Elberink JN. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy 2009, 64:1237-1245. 10.1111/j.1398-9995.2009.02118.x, 19627278.
41. González De Olano D, Alvarez-Twose I, Esteban-López MI, Sánchez-Muñoz L, de Durana MD, Vega A, García-Montero A, González-Mancebo E, Belver T, Herrero-Gil MD. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol 2008, 121:519-526. 10.1016/j.jaci.2007.11.010, 18177694.
42. Randolph CC, Reisman RE. Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy. J Allergy Clin Immunol 1986, 77:823-827. 10.1016/0091-6749(86)90379-9, 3711549.
43. Egner W, Ward C, Brown DL, Ewan PW. The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient. Clin Exp Allergy 1998, 28:26-34.
44. Reisman RE, Livingston A. Venom immunotherapy: 10 years of experience with administration of single venoms and 50 micrograms maintenance doses. J Allergy Clin Immunol 1992, 89:1189-1195. 10.1016/0091-6749(92)90304-K, 1607552.
45. Golden DB, Marsh DG, Kagey-Sobotka A, Freidhoff L, Szklo M, Valentine MD, Lichtenstein LM. Epidemiology of insect venom sensitivity. JAMA 1989, 262:240-244. 10.1001/jama.1989.03430020082033, 2739018.
46. Golden DB, Marsh DG, Freidhoff LR, Kwiterovich KA, Addison B, Kagey-Sobotka A, Lichtenstein LM. Natural history of Hymenoptera venom sensitivity in adults. J Allergy Clin Immunol 1997, 100:760-766. 10.1016/S0091-6749(97)70270-7, 9438483.